Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41.

× No keyword cloud information.

2 in total

1. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.

Authors: R Grunow; S Jahn; T Porstmann; S S Kiessig; H Steinkellner; F Steindl; D Mattanovich; L Gürtler; F Deinhardt; H Katinger
Journal: J Immunol Methods Date: 1988-02-10 Impact factor: 2.303

2. Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1.

Authors: A Jungbauer; C Tauer; E Wenisch; F Steindl; M Purtscher; M Reiter; F Unterluggauer; A Buchacher; K Uhl; H Katinger
Journal: J Biochem Biophys Methods Date: 1989 Aug-Sep

2 in total

15 in total

1. Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors: W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal: J Clin Invest Date: 1992-10 Impact factor: 14.808

2. New nucleotide sequence data on the EMBL File Server.

Authors:
Journal: Nucleic Acids Res Date: 1990-11-11 Impact factor: 16.971

3. Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response.

Authors: J S Andris; S Johnson; S Zolla-Pazner; J D Capra
Journal: Proc Natl Acad Sci U S A Date: 1991-09-01 Impact factor: 11.205

4. Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors: M Viau; M Zouali
Journal: J Clin Immunol Date: 2001-11 Impact factor: 8.317

5. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.

Authors: Catherine M Finnegan; Werner Berg; George K Lewis; Anthony L DeVico
Journal: J Virol Date: 2002-12 Impact factor: 5.103

6. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1.

Authors: Miroslaw K Gorny; Xiao-Hong Wang; Constance Williams; Barbara Volsky; Kathy Revesz; Bradley Witover; Sherri Burda; Mateusz Urbanski; Phillipe Nyambi; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner; Arthur Nadas
Journal: Mol Immunol Date: 2008-10-25 Impact factor: 4.407

Review 7. The molecular structure of human antibodies specific for the human immunodeficiency virus.

Authors: J S Andris; J D Capra
Journal: J Clin Immunol Date: 1995-01 Impact factor: 8.317

8. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.

Authors: X M He; F Rüker; E Casale; D C Carter
Journal: Proc Natl Acad Sci U S A Date: 1992-08-01 Impact factor: 11.205

9. Native-state stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris.

Authors: Graham Whyteside; Marcos J C Alcocer; Janet R Kumita; Christopher M Dobson; Maria Lazarou; Richard J Pleass; David B Archer
Journal: PLoS One Date: 2011-07-27 Impact factor: 3.240

10. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors: Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal: Biochem Biophys Res Commun Date: 2009-09-11 Impact factor: 3.575